Clinical Experience with Emicizumab and Rituximab as First-Line Treatment in a Case Series of Acquired Hemophilia A. [PDF]
Hematol RepOta H, Yasuda K, Toyota N, Masuoka K.
europepmc +1 more source
Postpartum Acquired Hemophilia A in Two Women With Previously Undiagnosed Carrier Status for von Willebrand Disease Type 2N and Heterozygous p.R854Q Mutation. [PDF]
HaemophiliaWeise M +4 more
europepmc +1 more source
Journal of the American College of Cardiology, 2016 Richard A. Chazal, Steven Houser
openaire +1 more source
Implications of the 2024 American Heart Association Classification of Cardiac Sarcoidosis: Characteristics and Outcome of Patients Across the Continuum of Diagnostic Likelihood. [PDF]
J Am Heart AssocMälkönen H +5 more
europepmc +1 more source
The "Lower Is Better" Debate in Hypertension Management: A Narrative Review of Divergent Recommendations in the 2024 ESC and 2025 ACC/AHA Guidelines. [PDF]
CureusVijaykumar V.
europepmc +1 more source
Emicizumab in the treatment of acquired hemophilia A: A Two-Center experience. [PDF]
Ann HematolSu M, Yates S, Sanchez M, Shen YM.
europepmc +1 more source
Refining Left Bundle Branch Block Activation Criteria in CRT Candidates: A Noninvasive Electrocardiographic Imaging Study. [PDF]
Diagnostics (Basel)Malishevskii L +9 more
europepmc +1 more source
Case Report: Telitacicept in the treatment of systemic lupus erythematosus complicated by acquired hemophilia A. [PDF]
Front ImmunolLiu X, Li W.
europepmc +1 more source
Limited Visibility and Perception of the Clinical Relevance of Clopidogrel Pharmacogenetics in Cardiology Literature. [PDF]
Clin Transl SciDello Russo C +5 more
europepmc +1 more source